article FILE – A woman holds a model of the human brain in her hands on June 1, 2019 in Cardiff, UK. (Photo by Matthew Horwood/Getty Images) Researchers are soon recruiting participants for a study aimed at preventing Alzheimer’s disease in people genetically destined to develop it at a young age. Depending on the result, …
article FILE – A woman holds a model of the human brain in her hands on June 1, 2019 in Cardiff, UK. (Photo by Matthew Horwood/Getty Images) Researchers are soon recruiting participants for a study aimed at preventing Alzheimer’s disease in people genetically destined to develop it at a young age. Depending on the result, …
CellCept (mycophenolate mofetil), an oral immunosuppressant used to prevent organ rejection, has been shown to be effective in treating a 10-year-old girl with severe atypical hemolytic uremic syndrome (aHUS). The researchers emphasized the importance of early diagnosis and careful monitoring in the recovery of patients. The study, “Atypical haemolytic uremic syndrome (aHUS) sensitive to mycophenolate …
CellCept transplant drug effectively treats aHUS in… Read More »
Antiviral drugs can suppress tumor adaptation to treatment and significantly prolong progression-free survival BUFFALO, NY – Researchers at the Roswell Park Comprehensive Cancer Center, working in collaboration with Genome Protection, Inc. and the Children’s Cancer Institute in Sydney, Australia, have discovered a new way in which highly repetitive genetic components belonging to the LINE-family 1 …
(CNN) – The investigational drug lecanemab shows “potential” as a treatment for Alzheimer’s disease, according to new Phase 3 trial results, but the results raise safety concerns because of its association with certain events serious adverse reactions. Lecanemab has become one of the first experimental dementia drugs to appear to slow the progression of cognitive …
Cajal aims to accelerate drug discovery for neurodegeneration by enabling target discovery and validation at unprecedented scale The team combines expertise in neuroscience, computational biology, high-throughput functional genomics and advanced microscopy Funding led by The Column Group and Lux Capital SEATTLE, November 29, 2022–(BUSINESS WIRE)–Cajal Neuroscience, a biotechnology company integrating human genetics, functional genomics and …
With the help of AI, researchers at Chalmers University of Technology in Sweden have succeeded in designing synthetic DNA that controls the protein production of cells. The technology can contribute to the development and production of vaccines, drugs for serious illnesses, as well as alternative dietary proteins much faster and at significantly lower costs than …
Research: AI adapts artificial DNA for future drug development | Sciences-Environment Read More »
image: AI adapts artificial DNA see After Credit: Credit: Yen Strandqvist With the help of an AI, researchers at Chalmers University of Technology in Sweden have succeeded in designing synthetic DNA that controls the production of proteins in cells. The technology can contribute to the development and production of vaccines, drugs for serious illnesses, as …
AI adapts artificial DNA for future drug development Read More »
Share on PinterestScientists can find new treatments for dementia by ensuring that all races are represented in clinical trials. Visual Vic/Getty Images The Alzheimer’s Association has called Alzheimer’s disease (AD) a “silent epidemic” among African American adults. Historically, however, African Americans have been less likely to participate in AD clinical studies. Researchers recently found that …
Blood pressure drug could reduce Alzheimer’s risk in older black adults Read More »
